Biological markers and diagnostic investigations in Alzheimer's disease

Acta Neurologica Scandinavica

Volumn 94, Issue SUPPL.165, 1996, Pages 85-91

  Wahlund, Lars Olaf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Biological marker; Diagnostic marker; Neuroimaging

Indexed keywords

BIOLOGICAL MARKER; AMYLOID PRECURSOR PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; HUMAN; REVIEW; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSIS; MUTATION; NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; HUMANS;

EID: 0029687360     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb05876.x     Document Type: Article

References (32)

1. Duara R. Neuroimaging with CT and MRI in Alzheimer disease. In: Terry RD, Katzman R., Bick KL, eds. Alzheimer disease. New York: Raven Press, 1994: 75-86.
2. Dahlbeck JW, McCluney KW, Yeakley JW et al. The interuncal distance: a new MR measurement for the hippocampal atrophy of Alzheimer disease. Am J Neuroradiol 1991: 12: 931-32.
3. Early B., Escalona PR, Boyko OB et al. Interuncal distance measurements in healthy volunteers and in patients with Alzheimer disease. Am J Neuroradiol 1993: 14: 907-10.
4. de Leon MJ, Golomb J., George AE et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. Am J Neuroradiol 1993: 14: 897-906.
5. Jobst KA, Smith AD, Szatmari M. et al. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet: 1992: 340: 1179-83.
6. Atlas S. Magnetic resonance imaging of the brain and spine. New York: Raven Press, 1991.
7. Mullan M., Crawford F., Axelman K. et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992: 1: 345-47.
8. Drayer BP. Imaging of the aging brain. I. Normal findings. Radiology 1988: 166: 785-96.
9. Erkinjuntti T., Hachinski VC. Rethinking vascular dementia. Cerebrovasc Dis 1993: 3: 3-23.
10. Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke 1986: 17: 1084-89.
11. Roman GC, Tatemichi TK, Erkinjuntti T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993: 43: 250-60.
12. Claus JJ, van Harskamp F., Breteler MM et al. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study. Neurology 1994: 44: 454-61.
13. Jobst KA, Smith AD, Barker CS et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992: 55: 190-94.
14. Nordberg A. Clinical studies in Alzheimer patients with positron emission tomography. Behav Brain Res 1993: 57: 215-24.
15. Nordberg A. Neuroreceptor changes in Alzheimer disease. Cerebrovasc Brain Metab Rev 1992: 4: 303-28.
16. Foster NL. PET imaging. In: Terry RD, Katzman R., Bick KL, eds. Alzheimer disease. New York: Raven Press, 1994: 87-103.
17. Belliveau JW, Rosen BR, Kantor HL, et al. Functional cerebral imaging by susceptibility-contact NMR. Magan Reson Med 1990: 14: 538-46.
18. Henriksen O. MRS of the brain. In: Certaines JD, Bovee WMM, Podo F., eds. Magnetic resonance spectroscopy in biology and medicine. Oxford, England: Pergamon Press, 1992: 411-33.
19. Miller BL, Moats RA, Shonk T., Ernst T., Woolley S., Ross BD. Alzheimer's disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993: 187: 433-37.
20. Basun H. Biological markers in Alzheimer's disease: diagnostic implications. Thesis. Stockholm, Sweden: Karolinska Institute, 1993.
21. Mandelkow EM, Mandelkow E. Tau as a marker for Alzheimer's disease. Trends Biochem Sci 1993: 18: 480-83.
22. Jensen M., Basun H., Lannfelt L. Increased cerebrospinal fluid tau in patients with Alzheimer's disease. Neurosci Lett 1995: 186: 189-91.
23. Van Nostrand WE, Wagner SL, Shankle WR et al. Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proc Natl Acad Sci USA 1992: 89: 2551-55.
24. Goate A., Chartier-Harlin MC, Mullan M. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991: 349: 704-6.
25. Nechiporuk A., Fain P., Kort E. et al. Linkage of familial Alzheimer disease to chromosome 14 in two large early-onset pedigrees: effects of marker allele frequencies on lod scores. Am J Med Genet 1993: 48: 63-66.
26. Pericak-Vance MA, Bebout JL, Gaskell PC Jr et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991: 48: 1034-50.
27. Strittmatter WJ, Weisgraber KH, Huang DY et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993: 90: 8098-102.
28. Strittmatter WJ, Saunders AM, Schmechel D. et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993: 90: 1977-81.
29. Katzman R. Apolipoprotein E4 as the major genetic susceptibility factor for Alzheimer disease. In: Terry RD, Katzman R., Bick KL, eds. Alzheimer disease. New York: Raven Press, 1994: 455-57.
30. Esiri MM, Wilcock GK. The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1984: 47: 56-60.
31. Koss E., Weiffenbach JM, Haxby JV, Friedland RP. Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology 1988: 38: 1228-32.
32. Serby M., Larson P., Kalkstein D. The nature and course of olfactory deficits in Alzheimer's disease. Am J Psychiatry 1991: 148: 357-60.